J.Safra Asset Management Corp Immunocore Holdings PLC Transaction History
J.Safra Asset Management Corp
- $1.54 Billion
- Q3 2025
A detailed history of J.Safra Asset Management Corp transactions in Immunocore Holdings PLC stock. As of the latest transaction made, J.Safra Asset Management Corp holds 75 shares of IMCR stock, worth $2,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 12
525.0%
Holding current value
$2,414
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
148Shares Held
45.1MCall Options Held
297KPut Options Held
1.19M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$228 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$157 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$136 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$121 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$78.6 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...